Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
-366,937
Put/Call ratio
72%
SEC-reported price per share
$116.63
Number of holders
349
Value change
+$55,229,563
Number of buys
189
Open additional details 1 more signal available
Number of sells
142
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
51,632,132

Security key

05464T104

Report period

Q1 2025

Institutions

349

Top holders

10

Ownership snapshot

Top reported holders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
0/15
Latest evidence
31 Dec 2024
13F Highest disclosed value: $342,785,993 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP has the largest disclosed position value at $342.79M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.
Disclosed position value Top 5
RTW INVESTMENTS, LP $342.79M
VANGUARD GROUP INC $330.19M
BlackRock, Inc. $298.96M
Fairmount Funds Management LLC $124.29M
BVF INC/IL $117.44M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$342,785,993
4,051,365 shares
— 31 Dec 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$330,188,748
3,902,479 shares
— 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$298,960,465
3,533,394 shares
— 31 Dec 2024
Fairmount Funds Management LLC
13F
Company
13F
—
denominator unverified
$124,290,652
1,468,983 shares
— 31 Dec 2024
BVF INC/IL
13F
Company
13F
—
denominator unverified
$117,444,095
1,388,064 shares
— 31 Dec 2024
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$84,610,000
1,000,000 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
349
Shares
36,999,749
Rows available
349
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders
349
Q1 2025 holders
349
Holder diff
0
Investor Q1 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2025 value Q1 2025 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .